by PhilipKotler (Author), Francoise Simon (Author), SimonFrancoise (Author)
Two leading marketing strategists Francoise Simon and Philip Kotler combine their expertise in the first ever book to offer cutting-edge global strategies for marketing biotechnology. With revolutionary biotechnological breakthroughs occurring in every sector, from medicine and defence to food and cosmetics, the twenty-first century is rapidly taking shape as the Biotech Century. Along with the enormous global opportunities presented by this revolution, however, businesses are faced with an array of unprecedented challenges in creating and sustaining brands in this extraordinarily fast-moving market. In MARKETING BIOTECHNOLOGY, two of marketing's prominent experts direct their attention to finding the solutions that specifically address the new, burgeoning biotech market. In creating this first-of-its-kind book, Francoise Simon and Philip Kotler have drawn on five years of consulting and research to show managers how bioscience and information technology can be combined to build powerful new business models. These models will help companies innovate with biotech networks, win customers with global bio brands, and create sustainable advantage worldwide.
Format: Hardcover
Pages: 400
Publisher: Simon & Schuster International
Published: 15 Sep 2003
ISBN 10: 074322244X
ISBN 13: 9780743222440
Chief Executive Officer, Novartis Pharmaceuticals
Building Global Biobrands provides important insights into the marketing of innovative medicines today, especially those with potentially lifesaving benefits. The authors explore the strategy for marketing breakthrough drugs and shed light on harnessing the power of activist patients and the escalating influence of the Internet.
Chief Medical Officer, Celera, and former Director, National Cancer Institute
Simon and Kotler have put together an extremely useful analysis of how innovation in the biosector is harnessed for success in the market.
Chairman and CEO, Biogen, Inc.
This book offers new thinking on the strategic challenges of biotech companies trying to build brands while navigating regulatory mine fields and rapid advances in biology and medical technology.
CEO, Burrill & Company
Lots of books have been written about the business of biotech, but few have been written about marketing and brands in the biopharma sector. This is a jewel. Simon and Kotler are timely, insightful, and readable. Enjoy.
President, Wyeth Pharmaceuticals
Building Global Biobrands tells the fascinating story of the biosector, its promises, and its daunting challenges. Global by necessity, biobrands require unprecedented resources and approaches to emerge and last. A must-read for anyone who wants to understand the Biotech Century.
Chairman and Chief Executive Officer, Human Genome Sciences
Building Global Biobrands is a thoughtful and original analysis of present and future trends in this exciting industry. It is a must-read for those in the biopharma business and for the general reader seeking insight about the most important technology in the twenty-first century.
Executive Vice President, Worldwide Sales and Marketing, Amgen
The essence of branding biopharma products is telling well the story of the match between product performance and customer needs. Simon and Kotler have provided a feast of examples of the branding strategies deployed with biopharma products. Their book will be a valuable reference for all students of branding.
FREE UK DELIVERY 
Global shipping from £2.99
FREE UK DELIVERY
30 Day Refund Guarantee
